Progress in the development of CRISPR genome editing technology and its application in ophthalmic disease

Journal Title: Eye Science (Yanke Xuebao) - Year 2021, Vol 36, Issue 7

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) genome editing is a newly developed technology to precisely modify cellular DNA sequence, which could control cell fate and phenotype and fundamentally reform disease treatment. The structure of the eye offers unique advantages as a genome editing target. Recently, a CRISPR genome editing therapy has begun to be tested in Leber congenital amaurosis 10(LCA10) patients, and the clinical trials for more ocular diseases are about to start. The development of CRISPR/Cas genome editing tools will drive major advances in the application of gene therapies in the treatment of ophthalmic disease.

Authors and Affiliations

Danbao MA, Weiye ZHONG, Chen YU

Keywords

Related Articles

Application progress of OCT measurement for ganglion cell complex thickness in high myopic eyes

Myopia prevention and control has risen to the national strategic level in China. Optic neuropathy caused by high myopia can damage visual function, but it is often ignored in clinical practice Optical coherence tomograp...

Application of local anesthesia assisted with sedation and analgesia of low-dose propofol combined with remifentanil in adult strabismus surgery

[Objective:] To explore the effect of local anesthesia assisted with sedation and analgesia of low-dose propofol combined with remifentanil in adult strabismus surgery. [Methods:] This study was a prospective cohort stud...

Exfoliation glaucoma: report of two cases

Exfoliation glaucoma is a category of glaucoma secondary to exfoliation syndrome, which is rarely encountered in clinical practice. We reported 2 cases with deposits of white material on the pupillary border of the iris....

Clinical efficacy of surgical resection of conjunctival papillae combined with autologous conjunctival graft in treatment of vernal keratoconjunctivitis

[Objective:] To evaluate the efficacy and safety of surgical resection of conjunctival papillae combined with autologous conjunctival graft in the treatment of vernal keratoconjunctivitis (VKC). [Methods:] All 11 cases (...

Management experience of multicenter clinical trial in ophthalmology

Because of the limitation of single-center clinical trials, more researchers attach importance to multicenter clinical trials. Only 6 multicenter clinical trials were registered on Chinese Clinical Trials Registry Center...

Download PDF file
  • EP ID EP763538
  • DOI 10.3978/j.issn.1000-4432.2021.06.19
  • Views 15
  • Downloads 0

How To Cite

Danbao MA, Weiye ZHONG, Chen YU (2021). Progress in the development of CRISPR genome editing technology and its application in ophthalmic disease. Eye Science (Yanke Xuebao), 36(7), -. https://www.europub.co.uk/articles/-A-763538